Communication through digital media vastly influences the perception of consumers regarding a product/service. Hence, pharmaceutical firms are constantly evolving to achieve a fair balance while advertising their products. Regulators, on the other hand, monitor the quality and authenticity of the data being published. In the case of COVID-19 vaccines, the significance of communication was the essence.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an international non-profit organization that strives to maintain an updated database to summon Regulatory Agencies and pharmaceutical manufacturers to discuss scientific and technical aspects of the industry on a single platform. Medical Dictionary for Regulatory Activities (MedDRA), owned and developed by ICH, is a distinct and standardized Regulatory dictionary that facilitates the communication of Regulatory information across the globe, seamlessly.
In the face of COVID-19 emergency, the European Medicines Agency (EMA) established faster scientific advice, rolling reviews and accelerated assessments to expedite the development and approval of medicinal products. EMA’s foresight is to support the development and marketing authorization of safe, effective and high-quality therapeutics and vaccines at the earliest. As claimed, EMA adapts rapid procedures to significantly cut-short the Regulatory timelines for the review of new medicines and vaccines against COVID-19.
Most of the life sciences companies now face increasing consumer, portfolio, regulatory and operating challenges on a daily basis as they carry on their search for innovative health solutions. In order to create and sustain competitive differentiation and market dominance, the life sciences sector must meet the diverse challenges of your regulatory/life cycle strategy today while supporting innovations of tomorrow.
CLOUD COMPUTING: UNDERSTANDING THE CLOUD HEMISPHERE